Press-release for stocks for takeda pharmaceutical company limited for NVAX

Prices are updated after-hours

Novavax Reports First Quarter 2022 Financial Results and Operational Highlights
Published: 2022-05-09 (Crawled : 22:00) - biospace.com/
TAK | News | $13.16 0.08% 0.53% 1.2M

| -9.87% | O: -0.69% H: 0.28% C: -1.1%
NVAX | $3.89 0.26% 2.1M

| -93.21% | O: 0.09% H: 5.27% C: -7.13%
results

Novavax Announces Submission of New Drug Application in Japan for Approval of COVID-19 Vaccine
Published: 2021-12-16 (Crawled : 05:00) - prnewswire.com
TAK | News | $13.16 0.08% 0.53% 1.2M

| -2.88% | O: 1.18% H: 0.0% C: 0.0%
NVAX | $3.89 0.26% 2.1M

| -97.71% | O: 5.55% H: 0.0% C: 0.0%
covid-19 new drug application drug approval covid vaccine submission

Novavax Reports Third Quarter 2021 Financial Results and Operational Highlights
Published: 2021-11-04 (Crawled : 23:00) - biospace.com/
TAK | News | $13.16 0.08% 0.53% 1.2M

| -7.65% | O: 0.35% H: 0.91% C: 0.77%
NVAX | $3.89 0.26% 2.1M

| -98.01% | O: -5.97% H: 2.42% C: -2.26%
financial results results

| -21.49% | O: 0.72% H: 0.5% C: -0.95%
NVAX | $3.89 0.26% 2.1M

| -98.24% | O: 1.81% H: 3.52% C: 2.54%
covid phase 1 vaccine license trial phase 3 phase 2

59%

41%

AGBA | News | $1.03 157.5% 57.94% 120M

ZCMD | $1.45 5.84% 52.1% 2.3M

INVO | $1.52 100.0% 51.13% 5M

ISPC | $0.421 97.65% 49.53% 37M

WLGS | News | $0.5 45.65% 470K

OST | $0.509 23.81% 45.26% 90K

GDHG | $0.263 21.76% 40.66% 3.1M

XPON | News | $3.15 63.21% 37.74% 16M

TIRX | $0.8 65.02% 30.74% 58M

BNTC | News | $6.82 42.08% 30.64% 3.5M

Save your searches and get alerts when important news are released.